Leading Financial Service Provider in India | Canara Bank Securities Ltd

Ajanta Pharma Ltd.

Jul 01 BSE 3346.80 ( -75.90 -2.22%)

Volume6313

Prev. Close
3422.70

Open Price
3420.00

Today's Low / High

3325.00 3505.55

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

2335.00 3505.55

Jul 01 NSE 3347.50( -75.20 -2.20%)

Volume99496

Prev. Close
3422.70

Open Price
3422.70

Today's Low / High

3316.00 3506.90

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

2329.90 3506.90

Market Cap. ( ₹ in Cr. )	41814.33	P/BV	9.24	Book Value ( ₹ )	362.42
52 Week High/Low ( ₹ )	3507/2330	FV/ML	2/1	P/E(X)	39.60
Book Closure	10/11/2025	EPS ( ₹ )	84.54	Div Yield (%)	0.84

(₹ in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1249.36	1249.12	1259.16	1259.15	854.16

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.07	25.07	25.27	25.27	17.17
Total Share Capital	25.07	25.07	25.27	25.27	17.17

Reserves and Surplus	4502.02	3765.22	3536.44	3362.38	3247.17
Total Reserves and Surplus	4502.02	3765.22	3536.44	3362.38	3247.17
Employees Stock Options	0.00	0.00	5.65	0.34	0.00
Total Shareholders Funds	4527.09	3790.29	3567.36	3387.99	3264.34

NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	1.25	1.64
Deferred Tax Liabilities [Net]	117.94	110.52	108.50	97.72	101.87
Other Long Term Liabilities	42.91	37.77	27.23	28.63	21.02
Long Term Provisions	51.15	80.27	39.54	24.15	19.32
Total Non-Current Liabilities	212.00	228.56	175.27	151.75	143.85

CURRENT LIABILITIES
Short Term Borrowings	211.99	2.59	1.49	0.18	0.27
Trade Payables	544.30	454.20	463.20	422.77	327.17
Other Current Liabilities	629.07	515.96	413.31	702.31	309.14
Short Term Provisions	30.39	23.35	17.76	14.02	10.81
Total Current Liabilities	1415.75	996.10	895.76	1139.28	647.39

Total Capital And Liabilities	6154.84	5014.95	4638.39	4679.02	4055.58

ASSETS
NON-CURRENT ASSETS
Tangible Assets	1825.37	1715.50	1464.53	1488.69	1502.97
Intangible Assets	41.58	46.52	14.66	7.75	9.02
Capital Work-In-Progress	258.05	176.27	256.45	209.47	152.86
Fixed Assets	2125.00	1938.29	1735.64	1705.91	1664.85
Non-Current Investments	28.50	25.24	18.58	25.10	25.10
Deferred Tax Assets [Net]	188.59	186.43	134.45	96.77	55.55
Other Non-Current Assets	77.32	21.96	18.80	17.24	45.62
Total Non-Current Assets	2419.41	2171.92	1907.47	1845.02	1791.12


CURRENT ASSETS
Current Investments	559.85	438.71	330.05	510.27	121.86
Inventories	938.54	903.85	828.36	815.63	791.07
Trade Receivables	1853.88	1182.74	1246.84	1056.90	1019.81
Cash And Cash Equivalents	104.77	176.24	130.77	330.90	211.79
Short Term Loans And Advances	1.68	2.54	33.96	17.39	6.37
OtherCurrentAssets	276.71	138.95	160.94	102.91	113.56
Total Current Assets	3735.43	2843.03	2730.92	2834.00	2264.46

Total Assets	6154.84	5014.95	4638.39	4679.02	4055.58

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	311.66	144.28	161.39	91.52	76.44

BONUS DETAILS
Bonus Equity Share Capital	15.50	15.50	15.63	15.63	7.09

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	28.50	25.24	18.58	0.00	0.00

CURRENT INVESTMENTS
Current Investments Quoted Market Value	333.69	428.59	299.15	510.27	121.86
Current Investments Unquoted Book Value	226.16	10.12	0.00	0.00	0.00

Particulars	Mar 26
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	2.00
No. of Equity Shares (in Lacs)	1249.36

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	25.07
Total Share Capital	25.07
Reserves and Surplus	4502.02
Total Reserves and Surplus	4502.02
Employees Stock Options	0.00
Total Shareholders Funds	4527.09
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00
Deferred Tax Liabilities [Net]	117.94
Other Long Term Liabilities	42.91
Long Term Provisions	51.15
Total Non-Current Liabilities	212.00
CURRENT LIABILITIES
Short Term Borrowings	211.99
Trade Payables	544.30
Other Current Liabilities	629.07
Short Term Provisions	30.39
Total Current Liabilities	1415.75
Total Capital And Liabilities	6154.84
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1825.37
Intangible Assets	41.58
Capital Work-In-Progress	258.05
Fixed Assets	2125.00
Non-Current Investments	28.50
Deferred Tax Assets [Net]	188.59
Other Non-Current Assets	77.32
Total Non-Current Assets	2419.41
CURRENT ASSETS
Current Investments	559.85
Inventories	938.54
Trade Receivables	1853.88
Cash And Cash Equivalents	104.77
Short Term Loans And Advances	1.68
OtherCurrentAssets	276.71
Total Current Assets	3735.43
Total Assets	6154.84
OTHER INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	311.66
BONUS DETAILS
Bonus Equity Share Capital	15.50
NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	28.50
CURRENT INVESTMENTS
Current Investments Quoted Market Value	333.69
Current Investments Unquoted Book Value	226.16

Markets

Balance Sheet

BALANCE SHEET

Ajanta Pharma Ltd.